Literature DB >> 29221595

Genetic and environmental risk factors for rheumatoid arthritis.

Kevin D Deane1, M Kristen Demoruelle2, Lindsay B Kelmenson2, Kristine A Kuhn2, Jill M Norris3, V Michael Holers2.   

Abstract

Multiple genetic and environmental factors have been associated with an increased risk for rheumatoid arthritis (RA). Of these, the strongest associations have been seen with female sex, a family history of RA, the genetic factor the "shared epitope," and exposure to tobacco smoke. There is also renewed interest in mucosal inflammation and microbial factors as contributors to the development of RA. However, the identification of a "preclinical" period of RA that can be defined as local or systemic autoimmunity as measured by autoantibodies and other biomarkers prior to the development of clinically apparent synovitis suggests that the risk factors for RA are acting long prior to first clinical evidence of IA. As such, a major challenge to the field will be to investigate the full spectrum of the development of RA, from initiation and propagation of autoimmunity during preclinical RA and transition to clinically apparent synovitis and classifiable RA, to determine which genetic and environmental factors are important at each stage of disease development. Understanding the exact role and timing of action of risk factors for RA is especially important given the advent of prevention trials in RA, and the hope that a full understanding of genetic and environmental factors in RA could lead to effective preventive interventions.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Microbiome; Mucosal inflammation; Preclinical rheumatoid arthritis; Rheumatoid arthritis environmental risk factors; Rheumatoid arthritis genetic risk factors; Rheumatoid arthritis prevention

Mesh:

Year:  2017        PMID: 29221595      PMCID: PMC5726551          DOI: 10.1016/j.berh.2017.08.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  164 in total

1.  Very high levels of anti-citrullinated protein antibodies are associated with HLA-DRB1*15 non-shared epitope allele in patients with rheumatoid arthritis.

Authors:  Judit Laki; Emeli Lundström; Omri Snir; Johan Rönnelid; Izabella Ganji; Anca I Catrina; Camilla Bengtsson; Saedis Saevarsdottir; Marius C Wick; Lars Alfredsson; Lars Klareskog; Leonid Padyukov
Journal:  Arthritis Rheum       Date:  2012-07

2.  Improved performance of epidemiologic and genetic risk models for rheumatoid arthritis serologic phenotypes using family history.

Authors:  Jeffrey A Sparks; Chia-Yen Chen; Xia Jiang; Johan Askling; Linda T Hiraki; Susan Malspeis; Lars Klareskog; Lars Alfredsson; Karen H Costenbader; Elizabeth W Karlson
Journal:  Ann Rheum Dis       Date:  2014-03-31       Impact factor: 19.103

3.  Expression of peptidylarginine deiminase-2 and -4, citrullinated proteins and anti-citrullinated protein antibodies in human gingiva.

Authors:  G P Harvey; T R Fitzsimmons; A A S S K Dhamarpatni; C Marchant; D R Haynes; P M Bartold
Journal:  J Periodontal Res       Date:  2012-09-16       Impact factor: 4.419

4.  Air pollution exposure increases the risk of rheumatoid arthritis: A longitudinal and nationwide study.

Authors:  Kuang-Hsi Chang; Chih-Chao Hsu; Chih-Hsin Muo; Chung Y Hsu; Hui-Chuan Liu; Chia-Hung Kao; Chiu-Ying Chen; Mei-Yin Chang; Yi-Chao Hsu
Journal:  Environ Int       Date:  2016-06-11       Impact factor: 9.621

Review 5.  The role of the microbiome in rheumatic diseases.

Authors:  Nigel Yeoh; Jeremy P Burton; Praema Suppiah; Gregor Reid; Simon Stebbings
Journal:  Curr Rheumatol Rep       Date:  2013-03       Impact factor: 4.592

6.  Sugar-sweetened soda consumption and risk of developing rheumatoid arthritis in women.

Authors:  Yang Hu; Karen H Costenbader; Xiang Gao; May Al-Daabil; Jeffrey A Sparks; Daniel H Solomon; Frank B Hu; Elizabeth W Karlson; Bing Lu
Journal:  Am J Clin Nutr       Date:  2014-07-16       Impact factor: 7.045

7.  The effect of olive oil and fish consumption on rheumatoid arthritis--a case control study.

Authors:  A Linos; E Kaklamanis; A Kontomerkos; Y Koumantaki; S Gazi; G Vaiopoulos; G C Tsokos; P Kaklamanis
Journal:  Scand J Rheumatol       Date:  1991       Impact factor: 3.641

8.  Antibodies to Porphyromonas gingivalis Indicate Interaction Between Oral Infection, Smoking, and Risk Genes in Rheumatoid Arthritis Etiology.

Authors:  Nastya Kharlamova; Xia Jiang; Natalia Sherina; Barbara Potempa; Lena Israelsson; Anne-Marie Quirke; Kaja Eriksson; Tülay Yucel-Lindberg; Patrick J Venables; Jan Potempa; Lars Alfredsson; Karin Lundberg
Journal:  Arthritis Rheumatol       Date:  2016-03       Impact factor: 10.995

Review 9.  Association between Air Pollution and the Development of Rheumatic Disease: A Systematic Review.

Authors:  Gavin Sun; Glen Hazlewood; Sasha Bernatsky; Gilaad G Kaplan; Bertus Eksteen; Cheryl Barnabe
Journal:  Int J Rheumatol       Date:  2016-10-25

10.  Autonomic Dysfunction Precedes Development of Rheumatoid Arthritis: A Prospective Cohort Study.

Authors:  F A Koopman; M W Tang; J Vermeij; M J de Hair; I Y Choi; M J Vervoordeldonk; D M Gerlag; J M Karemaker; P P Tak
Journal:  EBioMedicine       Date:  2016-02-19       Impact factor: 8.143

View more
  115 in total

1.  Regular use of proton pump inhibitor and risk of rheumatoid arthritis in women: a prospective cohort study.

Authors:  Jinqiu Yuan; Changhua Zhang; Jeffrey A Sparks; Susan Malspeis; Kelvin Kam-Fai Tsoi; Jean H Kim; Benjamin A Fisher; Fang Gao; Tim Sumerlin; Yan Liu; Yuxing Liu; Yihang Pan; Yulong He; Joseph J Y Sung
Journal:  Aliment Pharmacol Ther       Date:  2020-06-29       Impact factor: 8.171

2.  Autoantibodies against a novel citrullinated fibrinogen peptide related to smoking status, disease activity and therapeutic response to methotrexate in cuban patients with early rheumatoid arthritis.

Authors:  Goitybell Martínez; Eugen Feist; Maité Martiatu; Hilda Garay; Bárbara Torres
Journal:  Rheumatol Int       Date:  2020-05-29       Impact factor: 2.631

Review 3.  Immunometabolism in the development of rheumatoid arthritis.

Authors:  Cornelia M Weyand; Jörg J Goronzy
Journal:  Immunol Rev       Date:  2020-01-27       Impact factor: 12.988

Review 4.  Altering the natural history of rheumatoid arthritis: The role of immunotherapy and biologics in orthopaedic care.

Authors:  Steven J Girdler; Ivan Ye; Ray Tang; Noah Kirschner
Journal:  J Orthop       Date:  2019-07-01

5.  Timing of Elevations of Autoantibody Isotypes Prior to Diagnosis of Rheumatoid Arthritis.

Authors:  Lindsay B Kelmenson; Brandie D Wagner; Bryan K McNair; Ashley Frazer-Abel; M Kristen Demoruelle; Dylan T Bergstedt; Marie L Feser; Laura K Moss; Mark C Parish; Elizabeth A Mewshaw; Ted R Mikuls; Jess D Edison; V Michael Holers; Kevin D Deane
Journal:  Arthritis Rheumatol       Date:  2019-12-26       Impact factor: 10.995

Review 6.  Individuals at risk of seropositive rheumatoid arthritis: the evolving story.

Authors:  S Rantapää Dahlqvist; F Andrade
Journal:  J Intern Med       Date:  2019-10-21       Impact factor: 8.989

7.  Slicing and dicing myositis for cures and prevention.

Authors:  Frederick W Miller
Journal:  Nat Rev Rheumatol       Date:  2021-05       Impact factor: 20.543

Review 8.  Preclinical Rheumatoid Arthritis and Rheumatoid Arthritis Prevention.

Authors:  Kevin D Deane
Journal:  Curr Rheumatol Rep       Date:  2018-06-26       Impact factor: 4.592

Review 9.  Immune checkpoint inhibitor-induced inflammatory arthritis as a model of autoimmune arthritis.

Authors:  Laura C Cappelli; Mekha A Thomas; Clifton O Bingham; Ami A Shah; Erika Darrah
Journal:  Immunol Rev       Date:  2020-01-13       Impact factor: 12.988

Review 10.  Autoimmunity, inflammation, and dysbiosis mutually govern the transition from the preclinical to the clinical stage of rheumatoid arthritis.

Authors:  Alexander Kalinkovich; Gulzan Gabdulina; Gregory Livshits
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.